K-Raman Purushothaman

K-Raman Purushothaman

Auto-generated profile, based on publicly available information

K-Raman Purushothaman

Department of Dermatology, Mayo Clinic, Rochester, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Atherosclerosis
Verified
Journal Article
Closed access
PKPrakash Krishnan
Prakash Krishnan
KPK-Raman Purushothaman
K-Raman Purushothaman
MPMeerarani Purushothaman
Meerarani Purushothaman
ITIrene C. Turnbull
Irene C. Turnbull
ATArthur Tarricone
Arthur Tarricone
PMPedro R. Moreno
Pedro R. Moreno

15 May 2019 in Vascular Medicine
Verified
Journal Article
Open access
PDF file
PKPrakash Krishnan
Prakash Krishnan
PMPedro R Moreno
Pedro R Moreno
Irene  C. TurnbullIrene C. Turnbull
Irene C. Turnbull
MPMeerarani Purushothaman
Meerarani Purushothaman
MZMohammad Urooj Zafar
Mohammad Urooj Zafar
KPK-Raman Purushothaman
K-Raman Purushothaman
Diabetes mellitus (DM) and chronic kidney disease (CKD) separately are known to facilitate the progression of medial arterial calcification (MAC) in patients with symptomatic peripheral artery disease (PAD), but their combined effect on MAC and associated mediators of calcification is not well studied. The association of MAC and calcification inducer bone morphogenetic protein (BMP-2) and inhibitor fetuin-A, with PAD, is well known. Our aim was to investigate the association of MAC with alterations in BMP-2 and fetuin-A protein expression in patients with PAD with DM and/or CKD. Peripheral artery plaques (50) collected during directional atherectomy from symptomatic patients with PAD were evaluated, grouped into no-DM/no-CKD (n = 14), DM alone (n = 10), CKD alone (n = 12), and DM+CKD (n = 14). MAC density was evaluated using hematoxylin and eosin, and alizarin red stain. Analysis of inflammation, neovascularization, BMP-2 and fetuin-A protein density was performed by immunohistochemistry. MAC density, inflammation grade and neovessel content were significantly higher in DM+CKD versus no-DM/no-CKD and CKD (p < 0.01). BMP-2 protein density was significantly higher in DM+CKD versus all other groups (p < 0.01), whereas fetuin-A protein density was significantly lower in DM+CKD versus all other groups (p < 0.001). The combined presence of DM+CKD may be associated with MAC severity in PAD plaques more so than DM or CKD alone, as illustrated in this study, where levels of calcification mediators BMP-2 and fetuin-A protein were related most robustly to DM+CKD. Further understanding of mechanisms involved in mediating calcification and their association with DM and CKD may be useful in improving management and developing therapeutic interventions.

1 November 2019 in Cardiovascular Pathology
Verified
Journal Article
Closed access
PKPrakash Krishnan
Prakash Krishnan
KPK-Raman Purushothaman
K-Raman Purushothaman
MPMeerarani Purushothaman
Meerarani Purushothaman
ATArthur Tarricone
Arthur Tarricone
SCSimon Chen
Simon Chen
PMPedro R. Moreno
Pedro R. Moreno

1 July 2017 in Cardiovascular Pathology
Verified
Journal Article
Open access
KPK-Raman Purushothaman
K-Raman Purushothaman
MPMeerarani Purushothaman
Meerarani Purushothaman
ITIrene C. Turnbull
Irene C. Turnbull
DADavid H. Adams
David H. Adams
AAAnelechi Anyanwu
Anelechi Anyanwu
PMPedro R. Moreno
Pedro R. Moreno
Collagen cross-linking is mediated by lysyl oxidase (LOX) enzyme in the extracellular matrix (ECM) of mitral valve leaflets. Alterations in collagen content and LOX protein expression in the ECM of degenerative mitral valve may enhance leaflet expansion and disease severity. Twenty posterior degenerative mitral valve leaflets from patients with severe mitral regurgitation were obtained at surgery. Five normal posterior mitral valve leaflets procured during autopsy served as controls. Valvular interstitial cells (VICs) density was quantified by immunohistochemistry, collagen Types I and III by picro-sirius red staining and immunohistochemistry, and proteoglycans by alcian blue staining. Protein expression of LOX and its mediator TGFβ1 were quantified by immunofluorescence and gene expression by PCR. VIC density was increased, structural Type I collagen density was reduced, while reparative Type III collagen and proteoglycan densities were increased (P<.0001) with an increase in spongiosa layer thickness in myxomatous valves. These changes were associated with a reduction in LOX (P<.0001) and increase in TGFβ1 protein expression (P<.0001). However, no significant change was seen in gene expression. Linear regression analysis identified a correlation between Type I collagen density and LOX grade (R2=0.855; P<.0001). Reduced Type I collagen density with a simultaneous increase in Type III collagen and proteoglycan densities possibly contributes to spongiosa layer expansion resulting in incompetent mitral valve leaflets. Observed changes in Type I and III collagen densities in Degenerative Mitral Valve Disease may be secondary to alterations in LOX protein expression, contributing to disorganization of ECM and disease severity.

1 January 2013 in Cardiovascular Pathology
Verified
Journal Article
Closed access
KPK-Raman Purushothaman
K-Raman Purushothaman
PKPrakash Krishnan
Prakash Krishnan
MPMeerarani Purushothaman
Meerarani Purushothaman
JWJose Wiley
Jose Wiley
CACarlos L. Alviar
Carlos L. Alviar
PMPedro R. Moreno
Pedro R. Moreno

1 April 2016 in The American Journal of Cardiology
Verified
Journal Article
Closed access
PKPrakash Krishnan
Prakash Krishnan
KPK-Raman Purushothaman
K-Raman Purushothaman
MPMeerarani Purushothaman
Meerarani Purushothaman
UBUsman Baber
Usman Baber
ATArthur Tarricone
Arthur Tarricone
PMPedro R. Moreno
Pedro R. Moreno